These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 22617234)
1. Pathological classification of brain tumors. Pollo B Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostics of gliomas: the clinical perspective. Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485 [TBL] [Abstract][Full Text] [Related]
4. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
5. Neuropathological and molecular aspects of low-grade and high-grade gliomas. Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604 [TBL] [Abstract][Full Text] [Related]
6. [Histological and molecular classification of gliomas]. Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348 [TBL] [Abstract][Full Text] [Related]
7. Input of molecular analysis in medical management of primary brain tumor patients. Idbaih A; Duran-Peña A; Bonnet C; Ducray F Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669 [TBL] [Abstract][Full Text] [Related]
9. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas]. Idoate MA; Echeveste J Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212 [TBL] [Abstract][Full Text] [Related]
10. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337 [TBL] [Abstract][Full Text] [Related]
11. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362 [TBL] [Abstract][Full Text] [Related]
12. [OMICS and biomarkers of glial tumors]. Idbaih A Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetic markers as predictors of response to chemotherapy in gliomas. Idbaih A; Omuro A; Ducray F; Hoang-Xuan K Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460 [TBL] [Abstract][Full Text] [Related]
14. [Classification of gliomas. Current progress and perspectives]. Capper D; Reifenberger G Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737 [TBL] [Abstract][Full Text] [Related]
15. Molecular markers in low-grade gliomas: predictive or prognostic? Hartmann C; Hentschel B; Tatagiba M; Schramm J; Schnell O; Seidel C; Stein R; Reifenberger G; Pietsch T; von Deimling A; Loeffler M; Weller M; Clin Cancer Res; 2011 Jul; 17(13):4588-99. PubMed ID: 21558404 [TBL] [Abstract][Full Text] [Related]
16. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Marko NF; Prayson RA; Barnett GH; Weil RJ Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948 [TBL] [Abstract][Full Text] [Related]
17. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related]
18. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740 [TBL] [Abstract][Full Text] [Related]
19. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas]. Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078 [TBL] [Abstract][Full Text] [Related]
20. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile. Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]